T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$3.11B |
| 2 |
Meta Platforms (Facebook)
META
|
+$2.59B |
| 3 |
EQT Corp
EQT
|
+$1.31B |
| 4 |
Colgate-Palmolive
CL
|
+$1.08B |
| 5 |
Adobe
ADBE
|
+$1.06B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$1.92B |
| 2 |
UnitedHealth
UNH
|
+$1.78B |
| 3 |
Advanced Micro Devices
AMD
|
+$1.55B |
| 4 |
Ross Stores
ROST
|
+$1.54B |
| 5 |
ASML
ASML
|
+$1.49B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 31.61% |
| 2 | Healthcare | 16.91% |
| 3 | Consumer Discretionary | 11.05% |
| 4 | Financials | 10.6% |
| 5 | Communication Services | 9.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1901
Nu Skin
NUS
$236M
| $810K | ﹤0.01% |
24,393
+1,107
| +5% | +$40.8K |
|
1902
Leslie's
LESL
$7.21M
| $805K | ﹤0.01% |
4,284
+428
| +11% | +$88.4K |
|
|
VRE
1903
DELISTED
Veris Residential
VRE
| $805K | ﹤0.01% |
50,126
-565
| -1% | -$9.13K |
|
1904
Credo Technology Group
CRDO
$49.6B
| $804K | ﹤0.01% |
46,319
+11,757
| +34% | +$140K |
|
1905
MillerKnoll
MLKN
$1.64B
| $798K | ﹤0.01% |
53,971
+928
| +2% | +$14.8K |
|
|
SILK
1906
DELISTED
Silk Road Medical, Inc. Common Stock
SILK
| $795K | ﹤0.01% |
24,445
+1,370
| +6% | +$50K |
|
1907
Koppers
KOP
$857M
| $793K | ﹤0.01% |
23,243
+315
| +1% | +$10.3K |
|
1908
PureCycle Technologies
PCT
$1.41B
| $793K | ﹤0.01% |
74,131
+3,550
| +5% | +$25.7K |
|
|
NWLI
1909
DELISTED
National Western Life Group, Inc. Class A
NWLI
| $793K | ﹤0.01% |
1,907
-60
| -3% | -$19.1K |
|
1910
Pediatrix Medical
MD
$2.15B
| $792K | ﹤0.01% |
55,706
+1,243
| +2% | +$17.5K |
|
|
GAP
1911
The Gap Inc
GAP
$7.29B
| $792K | ﹤0.01% |
88,637
+4,615
| +5% | +$41.2K |
|
|
SASR
1912
DELISTED
Sandy Spring Bancorp Inc
SASR
| $788K | ﹤0.01% |
34,682
+634
| +2% | +$14.5K |
|
1913
Sunstone Hotel Investors
SHO
$2.01B
| $786K | ﹤0.01% |
77,603
+2,506
| +3% | +$25K |
|
1914
Tandem Diabetes Care
TNDM
$1.63B
| $786K | ﹤0.01% |
32,029
-259,162
| -89% | -$8.34M |
|
|
SAFE
1915
Safehold
SAFE
$1.09B
| $785K | ﹤0.01% |
33,043
+7,186
| +28% | +$191K |
|
|
BHR
1916
Braemar Hotels & Resorts
BHR
$139M
| $781K | ﹤0.01% |
194,065
+14,347
| +8% | +$56.6K |
|
1917
TriCo Bancshares
TCBK
$1.84B
| $781K | ﹤0.01% |
23,519
+291
| +1% | +$10.4K |
|
1918
Marathon Digital Holdings
MARA
$3.56B
| $777K | ﹤0.01% |
56,025
+11,518
| +26% | +$116K |
|
1919
NVE Corp
NVEC
$591M
| $777K | ﹤0.01% |
7,964
+966
| +14% | +$83.8K |
|
|
UTAA
1920
DELISTED
UTA Acquisition Corporation Class A Ordinary Shares
UTAA
| $777K | ﹤0.01% |
73,500
| – | – |
|
|
VISN
1921
Vistance Networks Inc
VISN
$2.67B
| $776K | ﹤0.01% |
137,764
+2,036
| +2% | +$9.73K |
|
1922
First Bancorp
FBNC
$2.72B
| $776K | ﹤0.01% |
26,052
-296,748
| -92% | -$9.38M |
|
1923
GlobalFoundries
GFS
$28.9B
| $775K | ﹤0.01% |
12,000
+2,166
| +22% | +$131K |
|
1924
Hanmi Financial
HAFC
$956M
| $775K | ﹤0.01% |
51,868
+1,778
| +4% | +$28.4K |
|
|
KE
1925
Kimball Electronics
KE
$606M
| $775K | ﹤0.01% |
28,025
+282
| +1% | +$6.67K |
|
Similar funds
T. Rowe Price Associates's Q2 2023 Portfolio in Review
As of Q2 2023, T. Rowe Price Associates held 3,044 positions worth $718B, up 7.4% from $668B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
T. Rowe Price Associates's Q2 2023 filing shows 123 new, 1,636 increased, 968 reduced and 150 closed positions. Its largest new stake was Kenvue: 26,317,608 shares worth $695M. The largest sale was Microsoft, an estimated $1.92B.
By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 30% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- T. Rowe Price Associates's largest Q2 2023 buy was Kenvue: 26,317,608 shares worth $695M.
- T. Rowe Price Associates added most to Amazon in Q2 2023, an estimated $3.11B increase.
- T. Rowe Price Associates's biggest Q2 2023 reduction was Microsoft, cutting an estimated $1.92B.
- T. Rowe Price Associates fully exited Canadian Natural Resources in Q2 2023, selling an estimated $112M.
- T. Rowe Price Associates's ten largest holdings make up 32% of its $718B portfolio in Q2 2023.
- T. Rowe Price Associates opened 123 new positions and closed 150 in Q2 2023.
- T. Rowe Price Associates's portfolio value rose 7.4% quarter-over-quarter to $718B.
Based on T. Rowe Price Associates's 13F filing for Q2 2023, filed 14 Aug 2023.